Steve Schey

A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients

H. G. Prentice, Ian Hann, Raoul Herbrecht et al. · British Journal of Haematology · 1997 · 438 citations

Medicine, Pharmacology, Pharmacotherapy +17

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial

Paul G. Richardson, Albert Oriol, Meral Beksaç et al. · The Lancet Oncology · 2019 · 385 citations · Full text

Medicine, Hematology, Pharmacotherapy +11

Outcomes after alemtuzumab-containing reduced-intensity allogeneic transplantation regimen for relapsed and refractory non-Hodgkin lymphoma

Emma Morris, Kirsty Thomson, Charles Craddock et al. · Blood · 2004 · 288 citations · Full text

Life Sciences, Immunology, Oncology +11

A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK

Karen Phekoo, Steve Schey, Martin Richards et al. · British Journal of Haematology · 2004 · 143 citations

Medicine, Hematology, Oncology +15

GCS-100, a novel galectin-3 antagonist, modulates MCL-1, NOXA, and cell cycle to induce myeloma cell death

Matthew Streetly, Lenushka Maharaj, Simon Joel et al. · Blood · 2010 · 132 citations · Full text

Medicine, Cell Biology, Oncology +16